Aventis reforms hit by takeover bid_2

A hostile takeover bid threatens to frustrate a major reorganisation of purchasing at Franco-German pharmaceutical group Aventis.

Even without the bid, finding key staff to deliver the benefits of a new global category management structure had proved difficult, according to Kai Nowosel, head of global purchasing, commercial operations at Aventis.

But the €46 billion bid by rival firm Sanofi-Synthelabo, currently going through the French courts, has made the task even tougher because a...

To continue reading this article you need to be registered with Recruiter . Registration is FREE and only takes minutes. Register here or sign in below if you already have an account.

Already registered? Login

Don't have an account?

Register for FREE today to access all premium online content and select your email preference.

We're here to help

If you have queries about accessing premium content, contact a Recruiter sidekick at mysidekick@recruiter.co.uk for more information or call +44 (0) 208 950 9117.

Top